Oxidized low density lipoprotein (LDL) possesses several atherogenic properties. The mechanisms by which LDL becomes oxidized in vivo remain unknown, but previous studies have suggested that 15-lipoxygenase may be one of the factors involved in the initiation of LDL oxidation in the arterial wall. 3 wk after a retrovirus-mediated 15-lipoxygenase gene transfer into iliac arteries of normocholesterolemic rabbits there was a threefold increase in 15-lipoxygenase activity but no signs of LDL oxidation. However, when animals were made moderately hypercholesterolemic by feeding a 0.13% cholesterol diet for 2-3 wk starting from day 4 after the gene transfer, oxidation-specific lipid-protein adducts characteristic of oxidized LDL were detected in 15-lipoxygenase-transduced arteries. Control experiments in which contralateral iliac arteries were transduced with (3-galactosidase-containing retroviruses showed only occasional signs of the presence of oxidation-specific adducts. The results support the hypothesis that products derived from the 15-lipoxygenase activity are involved in the induction of LDL oxidation within the arterial wall, provided that sufficient concentrations of lipoproteins are present in the artery. (J. Clin. Invest. 1995Invest. . 95:2692Invest. -2698
Introduction
A growing body of evidence suggests that oxidative modification of LDL plays an important role in atherogenesis (1) . Oxidized LDL is present in atherosclerotic lesions (2) (3) (4) (5) (6) (7) , it is avidly metabolized by macrophages (8) , cytotoxic to various cell types (9) , chemotactic for blood monocytes (10) , and induces formation of autoantibodies against oxidation-specific lipid-protein epitopes (4, 11, 12) . Inhibition of LDL oxidation also decreases the rate of development of atherosclerotic lesions in experimental animals (1, 13) . However, mechanisms leading to LDL oxidation in vivo remain unknown.
Lipoxygenases (LO)' are a family of enzymes which catalyze the deoxygenation of polyenoic fatty acids containing at least one 1,4-cis, cis-pentadiene structure, yielding corresponding fatty acid hydroperoxides as reaction products (14, 15) . So far, 5-, 12-, and 15-LO enzymes have been cloned from mammalian tissues (14, 15) . All biological functions of LOs are not yet known, but 15-LO seems to play a role in the peroxidation and breakdown of mitochondrial and other cellular membranes during reticulocyte maturation ( 16) . In vitro studies have suggested that 15-LO, but not 5-LO (17, 18) , may be one of the factors involved in the initiation of LDL oxidation. LDL treated with soybean 15-LO (9, 19) or recombinant human 15-LO (20) closely resembles oxidized LDL; enrichment of LDL with LO-derived peroxidation products promotes LDL oxidation in the presence of transition metals (21, 22) ; and several lipoxygenase inhibitors block cell-induced oxidation of LDL (17, (23) (24) (25) . It is not known whether 15 -LO induces LDL oxidation in vivo, but 15-LO mRNA and protein are expressed in macrophage-rich areas of atherosclerotic lesions in the same areas which contain epitopes characteristic of oxidized LDL (26, 27) . Atherosclerotic lesions also show higher levels of 15-LO enzyme activity and reaction products than corresponding normal arteries (28, 29) . Accordingly, it would be important to establish experimental models in which 15-LO expression is induced in the arterial wall. If 15-LO plays a role in LDL oxidation in vivo it should be possible to test the hypothesis by transferring 15-LO gene into normal arteries and determine whether this leads to the formation of epitopes characteristic of oxidized LDL.
To create such a model and to evaluate the role of 15-LO in the development of early atherosclerotic changes, we used a retrovirus-mediated 15-LO gene transfer into rabbit iliac arteries (30) . This model gives an opportunity for studying the effects of the gene in an anatomically defined portion of an artery (30) (31) (32) (33) (37) (Fig. 1) . 15-LO and P-galactosidase were expressed from the constructs by the 5'-LTR promoter. Poly A signal and repeated motifs presumably associated to translational repression (38) were omitted from the 3' untranslated end of 15-LO cDNA (Fig. 1) . Ecotropic (4i2) (39) and amphotropic (PA317) (40) producer cell lines were established using standard techniques (41) . Amphotropic cell lines produced replication-deficient retroviruses, which were able to transduce 15-LO and ,f-galactosidase activity into fibroblasts and smooth muscle cells in vitro2 (Table I) . Before use, the retroviruses were concentrated by a polyethylene glycol precipitation, and titers of the virus preparations were determined (41) . Concentrated virus stocks were free of helper virus activity as analyzed by the inability of concentrated viruses to spread the infection in F209 fibroblasts (41) .
Gene transfer was done in 16 4-6-mo-old New Zealand White rabbits. 10 concentrates (ALO17 for 15-LO; LZ915 for fi-galactosidase) were used in the study.
In each animal one iliac artery was transduced with the 15-LOcontaining retroviruses. In all but two animals, the contralateral iliac artery was handled exactly in the same way and transduced with the same retroviruses containing E. coli t3-galactosidase instead of 15-LO.
Prophylactic heparin and G-penicillin treatments were used in all experiments. Animals were free of helper virus production throughout the experiments, as judged by the absence of reverse transcriptase activity in plasma and urine samples (41) . Fasting plasma cholesterol levels were measured with enzymatic methods (Boehringer Mannheim, Mann- heim, Germany). All experiments were approved by the Experimental Animal Committee of the Universities of Kuopio and Tampere.
After the experimental period, arteries were either perfusion-fixed or perfused with phosphate-buffered saline and used for in situ hybridization, immunocytochemistry, and/or gas chromatographic analysis. Briefly, arteries were perfusion-fixed with 4% paraformaldehyde/5% sucrose containing 1 mM EDTA and 50 ,uM butylated hydroxytoluene as antioxidants, embedded in paraffin and/or OCT compound (Miles Inc., Kankakee, IL), and used for in situ hybridization and immunocytochemistry (26) . In situ hybridization was done on a set of serial sections as described (26, 27) . Briefly, 35S-UTP-labeled antisense and sense riboprobes for human reticulocyte 15-LO were synthesized from pBluescript vectors (Stratagene, La Jolla, CA) using T3 and T7 RNA polymerases (Promega Corp., Madison, WI) and applied on pretreated tissue sections (6 X 106 cpnmml) for 14 h at 53°C. The final wash after the hybridization was at 55°C in 0.1 x SSC for 30 min. Autoradiography (NTB-2; Eastman-Kodak Co., Rochester, NY) was used for the signal detection (26, 27) .
Immunocytochemistry was done as described (26, 42) . Both iliac arteries from the same animal were always immunostained simultaneously (avidin-biotin-horseradish peroxidase system; Vector Labs, Inc., Burlingame, CA) in a rigorously standardized way (26, 42) . Controls for the immunostainings included incubations with irrelevant class-and species-matched immunoglobulins and incubations where primary antibodies were omitted. Five serial sections taken from the middle portion of the experimental area were evaluated per artery for each of the antibodies. Immunostainings were evaluated by one examiner without knowledge of the origin of the samples. f3-Galactosidase activity was measured by X-gal staining as described (30) . To avoid any possible staining of endogenous fl-galactosidase activity present in macrophages, color development was only allowed to proceed for 6 h.
The following antibodies were used for the immunostainings: CD3 1 Intima/media thickness ratios were measured from five randomly selected sections per artery using a standard morphometry (46) . Measurements were done from all animals where gene transfer was successful. 15 -LO reaction products from isolated intima-medias of two normocholesterolemic and two moderately hypercholesterolemic animals were assayed with gas chromatography after reduction to hydroxyoctadecanoic acid (47) . Linoleic acid-derived reaction products (i.e., hydroxyoctadecanoic acid) were used as an indicator of 15-LO activity since they are present in higher concentrations and are more stable than arachidonic acid derivatives (15) . 15-LO activity in the transduced cell lines was measured after incubation of the mechanically disrupted cells with 50 /.M linoleic acid for 15 min at 37°C. Linoleic acid-derived reaction products were quantified-with gas chromatography after reduction to hydroxyoctadecanoic acid. More than 90% of the hydroxyoctadecanoic acid produced consisted of the 13-isomer, which is the specific reaction product of 15-LO when linoleic acid is used as a substrate2 (47) .
Results
Before in vivo experiments, retroviruses were tested for their ability to transduce eukaryotic cells in vitro. As shown in Table  I (Table II) , and there was a threefold increase in the chemically assayed arterial content of oxidized linoleic acid reaction products, which were used as an indicator of 15-LO activity (Table III) .
An example of the transduced gene expression is shown in Fig. 2 . /l-Galactosidase activity was detected in /3-galactosidase-transduced arteries (Fig. 2 a) , whereas it was not present in the 15-LO-transduced arteries (Fig. 2 d) Endothelial layer appeared morphologically intact in the transduced arteries (Fig. 3 c) . However, it is likely that some arterial injury was produced by the gene transfer procedure, since in preliminary experiments we found that catheterization alone or together with transduction using ,e3-galactosidase-containing retroviruses always caused diffuse intimal thickening. Similar thickenings were produced in this study, as indicated by an increased intima-media thickness ratio in the iliac arteries; however, there was no difference between 6-galactosidaseand 15-LO-transduced arteries (Table IE) . The thickening was mainly due to the proliferation of smooth muscle cells. An example is shown in Fig. 3 e. The cause of the vascular injury remains unknown. However, the findings may suggest that 15-LO activity and/or LDL oxidation may not play a significant role in smooth muscle cell proliferation and neointima formation.
After successful transduction of seven normocholesterolemic rabbits with 15-LO, only one animal showed a weak staining for oxidation-specific lipid-protein adducts in the iliac artery 3 wk after the gene transfer (Table II) . Since the arterial wall of a normal rabbit contains hardly any apoprotein Bcontaining lipoproteins, we used a 0.13% cholesterol diet to increase the influx of plasma lipoproteins into the arterial wall thickened by the manipulation (Fig. 3, d and i) . The diet was started 4 d after the gene transfer. 2-3 wk after the operation, four of the five arteries successfully transduced with 15-LO contained immunostaining for oxidation-specific lipid-protein adducts in the intima-media, whereas only one of the six contralateral control iliac arteries successfully transduced with /-galactosidase contained immunostaining for these adducts (Fig.  3 , c and h, Table IV) . Staining pattern was different in the experimental and control arteries: the intima-media of 15-LOtransduced arteries usually contained areas and groups of cells positive for both 15-LO protein and oxidation-specific lipidprotein adducts (Fig. 3, g and h) , whereas no such association was seen in the one control artery which stained positive for b C.... oxidized adducts (animal 16, Table IV ). In several areas of the 15-LO-transduced arteries, oxidized epitopes colocalized with immunostaining specific for apoprotein B (Fig. 3, h and i ). Very few macrophages were present in the thickened intimas of all studied animals ( Fig. 3 j) , which makes it highly unlikely that these cells were responsible for lipoprotein oxidation. As judged by immunostaining of serial sections, most of the cells expressing the transduced 15-LO appeared to be smooth muscle cells.
Discussion
The mechanism whereby LDL is oxidized in vivo remains unknown. It is likely that several pathways can lead to the appearance of oxidized LDL in the arteries (1, 48) . In vitro and in vivo studies have suggested that 15-LO may be one of the factors involved in the initiation of LDL oxidation in the arterial wall (19) (20) (21) (22) (23) (24) (25) (26) (27) The presence of oxidized epitopes in the iliac arteries was detected by immunocytochemical techniques using antibodies raised against MDA-modified LDL which is a model of oxidized LDL (2) (3) (4) . It should be noted that these antibodies also detect some other MDA-modified proteins, such as MDAalbumin (4, 42 Despite a measurable level of 15-LO expression in the transduced arteries, no oxidation-specific lipid-protein adducts were found in the arterial wall unless the animals were fed a cholesterol-enriched diet. Thus, the results suggest that both the expression of 15-LO and the presence of apoprotein B-containing lipoproteins in the arterial wall were required for the formation of oxidation-specific lipid-protein adducts, since (a) 15-LO expression alone did not lead to the appearance of oxidationspecific epitopes in normocholesterolemic animals; (b) except in one animal, /3-galactosidase-transduced control arteries in the cholesterol-fed group did not contain oxidized epitopes; and (c) oxidation-specific epitopes in the 15-LO-transduced arteries tended to colocalize with 15-LO protein and LDL apoprotein B immunostainings.
The results demonstrate that a definite, although modest, increase in 15-LO activity can be achieved in iliac arteries 2-3 wk after the transduction with 15-LO-containing retroviruses.
When compared with P6-galactosidase-transduced control iliac arteries, the 15-LO-transduced sites of the intima-media also exhibited a higher susceptibility to LDL oxidation as indicated by positive immunostaining for epitopes characteristic of oxidized LDL. The results support the hypothesis that 15-LO is one of the factors involved in LDL oxidation in the arterial microenvironment (19) (20) (21) (22) (23) (24) (25) (26) (27) . The model will be useful for the evaluation of localized oxidation-related early steps in the pathogenesis of atherosclerosis.
